Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.33 |
| ▸ | LDHB | P07195 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7771345 | 0.81 | KMT2A (0.39) | TDP1NOTUMCYP3A4ALDH1A1KDM4E | |
| SCHEMBL8641020 | 0.81 | TDP1 (0.38) | TDP1L3MBTL1NOTUMCYP3A4ACHE | |
| SCHEMBL3733647 | 0.79 | KDM4E (0.38) | TDP1L3MBTL1NOTUMCYP3A4ACHE | |
| SCHEMBL3392120 | 0.73 | TDP1 (0.48) | TDP1L3MBTL1NOTUMCYP3A4ACHE | |
| SCHEMBL16223153 | 0.70 | MEN1 (0.39) | TDP1NOTUMCYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL4278063 | 0.70 | MCL1 (0.35) | TDP1NOTUMCYP3A4ALDH1A1SMN1; SMN2 | |
| SCHEMBL355272 | 0.69 | TDP1 (0.61) | TDP1L3MBTL1NOTUMCYP3A4ALDH1A1 | |
| SCHEMBL6907913 | 0.67 | TDP1 (0.59) | TDP1L3MBTL1NOTUMCYP3A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6113042 | 0.67 | TDP1 (0.59) | TDP1L3MBTL1NOTUMCYP3A4ALDH1A1 | |
| SCHEMBL6916435 | 0.67 | TDP1 (0.59) | TDP1L3MBTL1NOTUMCYP3A4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AVENT, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AVANOS MEDICAL SALES, LLC | 2009-02-05 | — | — | US | disclosed |
| EP-1781098-A2 | ANTIMICROBIAL DEVICES AND COMPOSITIONS | ACRYMED, INC. (US) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006015317-A2 | ANTIMICROBIAL DEVICES AND COMPOSITIONS | ACRYMED, INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| US-4551350-A | AMINO PLAST | SWS SILICONES CORPORATION (US) | 1985-11-05 | — | — | US | disclosed |
| US-4520176-A | DILUENT, DURABLE PRESS RESIN CONTAINING AN AMINOPLAST AND AN ALOEHYDE | SWS SILICONES CORPORATION (US) | 1985-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10251392-B2 | Antimicrobial devices and compositions | AAAS, AOC1, COL14A1 | TDP1 4268/4885L3MBTL1 4200/4885NOTUM 3071/4885 |
| US-20090035342-A1 | Antimicrobial Devices and Compositions | AAAS, AOC1, COL14A1 | TDP1 4268/4885L3MBTL1 4200/4885NOTUM 3071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.